The estimated Net Worth of Michael A. Des Jardin is at least 24.8 百万$ dollars as of 2 March 2023. Mr. Jardin owns over 4,372 units of Horizon Therapeutics Plc stock worth over 14,718,695$ and over the last 14 years he sold HZNP stock worth over 10,119,171$. In addition, he makes 0$ as Executive Vice President - Technical Operations and Corporate Quality at Horizon Therapeutics Plc.
Michael has made over 21 trades of the Horizon Therapeutics Plc stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 4,372 units of HZNP stock worth 66,935$ on 2 March 2023.
The largest trade he's ever made was exercising 54,253 units of Horizon Therapeutics Plc stock on 4 January 2023 worth over 6,309,624$. On average, Michael trades about 10,770 units every 121 days since 2011. As of 2 March 2023 he still owns at least 126,558 units of Horizon Therapeutics Plc stock.
You can see the complete history of Mr. Jardin stock trades at the bottom of the page.
Michael A. DesJardin serves as Executive Vice President - Technical Operations and Corporate Quality of the Company. r. DesJardin previously served as our senior vice president, technical operations from October 2016 to November 2016 and as our senior vice president, life cycle management from December 2016 to January 2017. Mr. DesJardin joined Horizon from Raptor in October 2016 as part of the Raptor acquisition. While at Raptor, Mr. DesJardin was the senior vice president of technical operations from April 2015 to October 2016. Prior to that, Mr. DesJardin served as senior vice president of product development at Jazz Pharmaceuticals Public Limited Company (formerly Jazz Pharmaceuticals, Inc.) (Jazz) from July 2004 to March 2015. Mr. DesJardin spent nine years as an executive director and engineering fellow at ALZA Corporation and spent 15 years at the Dow Chemical Company working in pharmaceutical and agricultural chemical development for Marion Merrill Dow. Mr. DesJardin has over 39 years of experience in pharmaceutical development.
Michael DesJardin is 62, he's been the Executive Vice President - Technical Operations and Corporate Quality of Horizon Therapeutics Plc since 2017. There are 6 older and 18 younger executives at Horizon Therapeutics Plc. The oldest executive at Horizon Therapeutics Plc is William Daniel, 67, who is the Independent Director.
Michael's mailing address filed with the SEC is C/O HORIZON THERAPEUTICS PLC,, 70 ST. STEPHEN?S GREEN, DUBLIN, L2, D02 E2X4.
Over the last 13 years, insiders at Horizon Therapeutics Plc have traded over 454,905,275$ worth of Horizon Therapeutics Plc stock and bought 11,809,010 units worth 58,823,653$ . The most active insiders traders include Jeff Himawan、Woodlands Health Ventures F...、Jean Francois Formela. On average, Horizon Therapeutics Plc executives and independent directors trade stock every 13 days with the average trade being worth of 12,248,018$. The most recent stock trade was executed by Gino Santini on 2 October 2023, trading 23,092 units of HZNP stock currently worth 351,691$.
at horizon therapeutics, we believe science and compassion must work together to transform lives. we are driven to deliver innovative medicines to those living with rare, autoimmune and severe inflammatory diseases because we uniquely understand the patient journey. for us, success is measured by the numbers that matter most – the number of lives we touch, the number we change and those we work to help save.
Horizon Therapeutics Plc executives and other stock owners filed with the SEC include: